Consensus document (SEMES-SEMICYUC). Recommendations for the initial and multidisciplinary diagnostic management of severe sepsis in the hospital Emergency Departments;Documento de Consenso (SEMES-SEMICYUC). Recomendaciones del manejo diagnóstico-terapéutico inicial y multidisciplinario de la sepsis grave en los Servicios de Urgencias hospitalarios

Medicina Intensiva

Volumn 31, Issue 7, 2007, Pages 375-387

  Leon Gil C ^a,b   Garcia Castrillo Riesgo L ^a   Moya Mir, M ^a   Artigas Raventos A ^a   Borges Sa, M ^a   Candel Gonzalez F J ^a   Chanovas Borras M ^a   Ferrer Roca, R ^a   Jimenez A J ^a   Loza Vazquez A ^a   Sanchez Garcia M ^a  

^a Sociedad Española de Medicina de Urgencias y Emergencias SEMES   (Spain)

^b HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; GLUCOCORTICOID;

ANTIBIOTIC THERAPY; CONFERENCE PAPER; CONSENSUS; ELECTROCARDIOGRAM; HEMODYNAMICS; HOSPITAL SERVICE; HUMAN; INTENSIVE CARE; SEPSIS; SPAIN;

EID: 35448964779     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/S0210-5691(07)74842-8     Document Type: Conference Paper

References (42)

1. Grupo para el Estudio de la Infección en Urgencias. Estudio epidemiológico de las infecciones en el Área de urgencias. Emergencias. 2000;12:80-9.
2. Martínez Ortiz de Zárate M. Aspectos epidemiológicos de las infecciones en las Áreas de Urgencias. Emergencias. 2001;13:S44-S50.
3. Olivan Ballabriga AS, Agudo Pascual O, Agorreta Ruiz J, Pinillos Echevarría MA, Etxebarria Lus M, Moros Morgoñón MA, et al. La patología infecciosa en el Servicio de Urgencias de un hospital terciario. Emergencias 1998;10 Supl 1:22-5.
4. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-74.
5. Levy MM, Fink M P, Marshall JC, Abraham E, Angus D, Cook D, et al. "2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference". Intensive Care Med. 2003;29:530-8.
6. De Miguel-Yanes JM, Andueza-Lillo JA, González-Ramallo VJ, Pastor l, Muñoz J. Failure to implement evidence-based clinical guidelines for sepsis at the EDB. Am J Emerg Med. 2006;24:553-9.
7. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B, for the CUB-Réa Network. Current epidemiology of septic shock. Am J Respir Crit Care Med. 2003;168:165-72.
8. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546-54.
9. Esteban A, Frutos-Vivar F, Ferguson ND, Gordo F, Honrubia T, Penuelas O, et al. Incidence and Outcome of Sepsis in an Health Area from Madrid, Spain. Orlando: 100 th International Conference ATS; 2004.
10. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303-10.
11. Padkin A, Goldfrad C, Brady AR, Young D, Black N, Rowan K. Epidemiology of severe sepsis ocurring in the first 24 hours in intensive care units in England, Wales and Northern Ireland. Crit Care Med. 2003;31:2332-8.
12. Íñigo J, Sendra JM, Díaz R, Bouza C, Sarria-Santamera A. Epidemiología y costes de la sepsis grave en Madrid. Estudio de altas hospitalarias. Med Intensiva. 2006;30:197-203.
13. Alberti C, Brun-Buisson C, Goodman SV, Guidici D, Granton J, Moreno R, et al. Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med. 2003;168:77-84.
14. Rangel-Frausto MS, Pittet D, Hwang T, Woolson RF, Wenzel R. The dynamics of disease progression in sepsis: Markov modeling describing the natural history and the likely impact of effective antisepsis agents. Clin Infect Dis. 1998;27:185-90.
15. Garnacho Montero J, García Garmendía JL, Barrero Almodóvar AE, Jiménez Jiménez FJ, Pérez Paredes C, Ortiz Leyba C. Impact of adequate empirical antibiotic therapy on the outcome in patients admitted to the ICU with sepsis. Crit Care Med. 2003;31:2742-51.
16. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589-96.
17. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis and Septic Shock. Intensive Care Med. 2004;30:536-55.
18. Marquis S, Roupie E. Prise en charge précoce du choc septique aux urgencies. Réanimation. 2006;15:507-13.
19. Groupe transversal sepsis. Prise en charge initiale des états septiques graves de l'adulte et de l'enfant. Réanimation. 2007;17:S1-S21.
20. Puyol Rojo M, León Gil C. Sepsis, sepsis grave y shock séptico. En: Ausina Ruiz V, Moreno Guillén S, editores. Tratado SEIMC de enfermedades infecciosas y microbiología clínica. Madrid: Panamericana; 2006. p. 1339-42.
21. Ferrer R. Edusepsis Investigators. Surviving sepsis campaign in Spain: differences between perception and objective implementation. Intensive Care Med 2006;32 Suppl: S22.
22. Andreu LM, Alonso-Tarrés C, Echevarría Mayo JM. Diagnóstico de las enfermedades infecciosas. En: Ausina V, Moreno S, editores. Tratado SEIMC de Enfermedades Infecciosas y Microbiología Clínica. Capítulo 4. Madrid: Ed Panamericana; 2005. p. 53-70.
23. Millar JM, Colmes HT, Krisher K. General principles of specimen collection and handling. En: Murray P, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, et al, editors. Manual of Clinical Microbiology. Chapter 6. 8th. ed. ASM press; 2003. p. 55-66.
24. Nguyen B, Rivers E, Abrahamian A, Moran J, Abraham E, Trzeciak J, et al. Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med. 2006;48:28-54.
25. Bochud PY, Bonten M, Marchetti O, Calandra T. Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review. Crit Care Med. 2004;32 Suppl:S495-S512.
26. Russell JA. Management of sepsis. N Engl J Med. 2006;355:1699-713.
27. ATS Documents. "Guidelines for the managements of adults with hospital-acquired, ventilator-associated and health care-associated pneumonia". Am J Respir Crit Care Med. 2005;171:388-416.
28. Álvarez F, Bouza E, García-Rodríguez JA, Mensa J, Picazo JJ, Sobradillo V, et al. Second consensus statement on the use of antimicrobial drugs in chronic obstructive pulmonary disease exacerbations. Rev Esp Quimioter. 2002;15:375-85.
29. Marshall JC, Maier RV, Jiménez M, Dellinger EP. Source control in the management of severe sepsis and septic shock: an evidence-based review. Crit Care Med. 2004; 32 Suppl:S513-S26.
30. Otero RM, Nguyen HB, Huang DT, Gaieski DF, Goyal M, Gunnerson KJ, et al. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest. 2006;130:1579-95.
31. Bourgoin A, Leone M, Delmas A, Garnier F. Albanese J, Martin C. Increasing mean arterial pressure in patients with sepsic shock: effects on oxygen variables and renal function. Crit Care Med. 2005;33:780-6.
32. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368-77.
33. Michard F, Teboul JL. Predicting fluid responsiveness in ICU patients: a critical analyisis of the evidence. Chest. 2002;121:2000-8.
34. Len Abad O. Sepsis y shock séptico. Medicine. 2006;9:3211-8.
35. Sepsis, Sepsis Grave y Shock septico. En: Mensa J, Gatell JM, editores. Infecciones en Urgencias. Capítulo 73. 5th ed. Antares; 2005. p. 476-9.
36. Hedlund J, Stralin K, Ortqvist A, Holmberg H. Swedish guidelines for the management of community-acquired pneumonia in immunocompetent adults. Scand J Infect Dis. 2005;37(11-12):791-805.
37. Weiss K, Tillotson GS. The controversy of combination vs monotherapy in the treatment of hospitalized community-acquired pneumonia. Chest. 2005;128:940-6.
38. Solomkin JS, Mazuski JE, Baron EJ, Sawyer RG, Nathens AB, DiPiro JT, et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis. 2003;37:997-1005.
39. Naber KG, Bergman B, Bishop MC, Bjerklund-Johansen TE, Botto H, Lobel B, et al. EAU Guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol. 2001;40:576-88.
40. Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41:1373-406.
41. Wong CH, Wang YS. The diagnosis of necrotizing fascitis. Curr Opin Infect Dis. 2005;18:101-6.
42. Rivers E. The outcome of patients presenting to the emergency department with severe sepsis or septic shock. Crit Care. 2006;10:154.